3D Medicines Inc

HKSE:01244 (China)  
HK$ 3.34 (+6.71%) Dec 23
At Loss
P/B:
0.90
Market Cap:
HK$ 818.44M ($ 105.37M)
Enterprise V:
HK$ 5.17M ($ 666.00K)
Volume:
144.00K
Avg Vol (2M):
674.73K
Trade In:
Volume:
144.00K
At Loss
Avg Vol (2M):
674.73K

Business Description

Description
3D Medicines Inc is a commercial-stage biopharmaceutical company that researches, develops, and commercialization drugs in the field of managing cancer as a chronic disease. It develops differentiated immuno-oncology drugs, helping cancer patients live with prolonged survival time and quality of life. It generates all of its revenue from China.
Name Current Vs Industry Vs History
Cash-To-Debt 3.46
Equity-to-Asset 0.67
Debt-to-Equity 0.31
Debt-to-EBITDA -0.57
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.61
Distress
Grey
Safe
Beneish M-Score 0.86
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 4.3
3-Year EPS without NRI Growth Rate 8.7
3-Year FCF Growth Rate 18.7

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 51.69
9-Day RSI 59.17
14-Day RSI 59.97
6-1 Month Momentum % -67.17
12-1 Month Momentum % -73.01

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.58
Quick Ratio 2.56
Cash Ratio 2.24
Days Inventory 63.56
Days Sales Outstanding 43.54
Days Payable 525.69

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.3
Shareholder Yield % -33.88

Financials

HKSE:01244's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

3D Medicines Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$) 531.101
EPS (TTM) (HK$) -2.104
Beta 0
Volatility % 58.78
14-Day RSI 59.97
14-Day ATR (HK$) 0.344128
20-Day SMA (HK$) 2.4935
12-1 Month Momentum % -73.01
52-Week Range (HK$) 1.6 - 8.45
Shares Outstanding (Mil) 245.04

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

3D Medicines Inc Filings

Filing Date Document Date Form
No Filing Data

3D Medicines Inc Stock Events

Financials Calendars
Event Date Price(HK$)
No Event Data

3D Medicines Inc Frequently Asked Questions

What is 3D Medicines Inc(HKSE:01244)'s stock price today?
The current price of HKSE:01244 is HK$3.34. The 52 week high of HKSE:01244 is HK$8.45 and 52 week low is HK$1.60.
When is next earnings date of 3D Medicines Inc(HKSE:01244)?
The next earnings date of 3D Medicines Inc(HKSE:01244) is .
Does 3D Medicines Inc(HKSE:01244) pay dividends? If so, how much?
3D Medicines Inc(HKSE:01244) does not pay dividend.

Press Release

Subject Date
No Press Release